Diabetes Clinical Trials in San Francisco

Showing 121-140 of 255 trials

Health Coach Program to Improve Chronic Disease Outcomes Following an Emergency Department Visit

NCT02386540

The purpose of this study is to determine whether health coaching initiated in the emergency department (ED) reduces subsequent ED visits, increases primary care visits, and positively impacts health outcomes in patients with diabetes and/or hypertension.

Diabetes MellitusHypertension

Alameda County Medical Center295 participantsStarted Feb 2015

Oakland, California, United States

COMPLETEDPHASE28.4 miles

Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM

NCT02526524

The purpose of the study is to compare the glycemic effects of delayed-release metformin (Met DR) to placebo in subjects with type 2 diabetes mellitus (T2DM) over 16 weeks. The study is designed to evaluate several doses of Met DR (600 to 1500 mg once daily in the morning \[qAM\]) compared to placebo. A single-blind reference treatment of 2000 mg metformin immediate-release (Met IR) per day administered as equal divided doses (1000 mg Met IR BID) will also be included.

Type 2 Diabetes Mellitus

Elcelyx Therapeutics, Inc.571 participantsStarted Sep 2015

Anniston, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +134 more locations

Health Coach Program to Improve Chronic Disease Outcomes Following an Emergency Department Visit

Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM

Diabetes Trials in Other Cities

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine

Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

DTS Blood Glucose Monitor System Surveillance Program SubStudy 1

Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor

Evaluation of the Accuracy of an Implanted Glucose Sensor

Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes

A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes

A Study in Participants With Type 2 Diabetes Mellitus

International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol

Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects

Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Other Conditions in San Francisco